Jammi Pharmaceuticals Private Limited

Jammi Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U85310TN2018PTC122433 Incorporated 02 May 2018 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2025
₹4.45 Cr
▲ 59% YoY
Net profit · FY 2025
₹11.7 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹35.53 Lakh
EBITDA margin 8%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹32.06 Lakh
Issued & subscribed
Open charges
₹1.7 Cr
Satisfied ₹80.5 Lakh
Company age
8 yrs
Est. 2018
Employees · EPFO
42
Provident fund records

About Jammi Pharmaceuticals Private Limited

Data last updated:

Jammi Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 May 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85310TN2018PTC122433. Its GSTIN is 33AAECJ2471R1Z6 (Tamil Nadu).

The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹32.06 Lakh. It is led by directors Narasimham V Jammi and Anitha Balachander.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.45 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹11.7 Lakh (net margin 2.6%) and EBITDA of ₹35.53 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 36% over five years.

The company has about 42 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Jammi. As per MCA filings, the company has open charges of ₹1.7 Cr and satisfied charges of ₹80.5 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company.

Jammi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0036263). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jammi.in.

Company details

CIN U85310TN2018PTC122433
Registration Number 122433
Incorporation Date 02 May 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0036263

Recognitions & Rankings of Jammi Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-TN-02-0036263

Contact details

Jammi Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is jammi.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    Abhirami Apartments, Old No 20 New No 14 Flat No 2B 2nd Floor Dr Nair Road T Nagar, Chennai, Tamil Nadu, India – 600017
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Jammi Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Jammi Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Jammi Pharmaceuticals operates one associated brand: Jammi. Each brand links to its own profile.

BrandDescriptionWebsite
Ayurvedic pharmaceutical products and wellness services in Chennai.jammi.in

Business activity

The main business activity of Jammi Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Jammi Pharmaceuticals Private Limited, buy the company report.

Financials of Jammi Pharmaceuticals Private Limited

FY 2025 filings available

Jammi Pharmaceuticals Private Limited reported revenue of ₹4.45 Cr (up 59% YoY) for FY 2025.

Revenue · FY 2025
₹4.45 Cr ▲ 59%
Net profit · FY 2025
₹11.7 Lakh margin 2.6%
EBITDA · FY 2025
₹35.53 Lakh margin 8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 29%
5 years · compounded
▲ 36%
EBITDA CAGR growth
5 years · compounded
▲ 56%

Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 59% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations₹4.45 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹35.53 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹11.7 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8%
Net Profit Margin2.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jammi Pharmaceuticals Private Limited, buy the company report.

Board of directors of Jammi Pharmaceuticals Private Limited

Jammi Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narasimham V JammiDirector02 May 20188 Years 6 MonthsCurrent
Anitha BalachanderAdditional Director07 Jul 20215 Years 4 MonthsCurrent

Auditor

Jammi Pharmaceuticals Private Limited is audited by SHUBHADRA & AJIT for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SHUBHADRA & AJITFY 2023012151S

Shareholding

The shareholding of Jammi Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jammi Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.7 Cr
Satisfied charges
₹80.5 Lakh
Breakdown by lending institutions
Bank of India₹1.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Sep 2025101169769Bank of India₹1.7 CrOpen
10 Aug 2022100610298Others₹80.5 LakhSatisfied

To see the full charge records of Jammi Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Jammi Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 5 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (3 of 3)

SupplierAmount dueDue sinceReported on
an individual supplier
Parle Tableting Technologies Private Limited
an individual supplier

To see the full MSME payment records of Jammi Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Jammi Pharmaceuticals Private Limited has a workforce of 42 employees on its EPFO records as of Jun 2023, across 3 active EPFO establishments.

Employee count
42
Active EPFO establishments
3
Employee growth
-20.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2023-2442
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Jammi Pharmaceuticals Private Limited, buy the company report.

GST

Jammi Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAECJ2471R1Z6Tamil NaduActive08 Jun 2018

To see the full GST registrations and return filing status of Jammi Pharmaceuticals Private Limited, buy the company report.

Recent activity

Jammi Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jammi Venkata Butchi Lakshmirama Narasu ceased to be Director on 08 Jul 2025.

AGM
Jammi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 10 Aug 2022 via Charge ID 100610298 with Others was fully satisfied on 30 Sep 2025.
Charges
A charge with Bank Of India amounted to Rs. 169.63 Lakh with Charge ID 101169769 was registered on 23 Sep 2025.
Ceased
Jammi Venkata Butchi Lakshmirama Narasu ceased to be Director.
Filing
Jammi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 80.50 Lakh with Charge ID 100610298 was registered on 10 Aug 2022.
Appointed
Anitha Balachander was appointed as Additional Director.
Appointed
Narasimham V Jammi was appointed as Director.
Incorporation
02 May 2018
Jammi Pharmaceuticals Private Limited was registered on 02 May 2018 with Roc Chennai & aged 8 years 6 months as per MCA records.

Frequently asked questions

Jammi Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 May 2018 (8+ years old) and is registered under CIN U85310TN2018PTC122433.

Jammi Pharmaceuticals has 2 current directors:

The latest financial statements of Jammi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Jammi Pharmaceuticals is 33AAECJ2471R1Z6, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Jammi Pharmaceuticals is U85310TN2018PTC122433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jammi Pharmaceuticals has 3 court cases on record: 3 filed by the company.

Jammi Pharmaceuticals was incorporated on 02 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.

Jammi Venkata Butchi Lakshmirama Narasu ceased to be Director on 08 Jul 2025. Anitha Balachander was appointed as Additional Director on 07 Jul 2021. Narasimham V Jammi was appointed as Director on 02 May 2018.

Yes, Jammi Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Jammi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0036263).

Jammi Pharmaceuticals has 2 MSME Form 1 returns on record between 2019 and 2020, listing 5 overdue payments to 3 micro and small suppliers. The latest return was filed on 31 Dec 2020.